Detection of the novel SARS-CoV-2 European lineage B.1.177 in Ontario, Canada

• Published in: Journal of clinical virology plus 2021-06, Vol.1 (1-2), p.100010-100010, Article 100010
• Main Authors: Guthrie, Jennifer L., Teatero, Sarah, Zittermann, Sandra, Chen, Yao, Sullivan, Ashleigh, Rilkoff, Heather, Joshi, Esha, Sivaraman, Karthikeyan, de Borja, Richard, Sundaravadanam, Yogi, Laszloffy, Michael, Heisler, Lawrence, Allen, Vanessa G., Simpson, Jared T., Fittipaldi, Nahuel
• Format: Article
• Language: English
• Subjects: Canada; COVID-19; Ontario; SARS-CoV-2; Short Communication; Whole-genome sequencing
• ISSN: 2667-0380; 2667-0380
• DOI: 10.1016/j.jcvp.2021.100010

Travel-related dissemination of SARS-CoV-2 continues to contribute to the global pandemic. A novel SARS-CoV-2 lineage (B.1.177) reportedly arose in Spain in the summer of 2020, with subsequent spread across Europe linked to travel by infected individuals. Surveillance and monitoring through the use of whole genome sequencing (WGS) offers insights into the global and local movement of pathogens such as SARS-CoV-2 and can detect introductions of novel variants. We analysed the genomes of SARS-CoV-2 sequenced for surveillance purposes from specimens received by Public Health Ontario (Sept 6 – Oct 10, 2020), collected from individuals in eastern Ontario, which comprised the study sample. Taxonomic lineages were identified using pangolin (v2.08) and phylogenetic analysis incorporated publicly available genomes covering the same time period as the study sample. Epidemiological data collected from laboratory requisitions and standard reportable disease case investigation was integrated into the analysis. Genomic surveillance identified a COVID-19 case with SARS-CoV-2 lineage B.1.177 from an individual in eastern Ontario in late September, 2020. The individual had recently returned from Europe. Genomic analysis with publicly available data indicate the most closely related genomes to this specimen were from Southern Europe. Genomic surveillance did not identify further cases with this lineage. Genomic surveillance allowed for early detection of a novel SARS-CoV-2 lineage in Ontario which was deemed to be travel related. This type of genomic-based surveillance is a key tool to measure the effectiveness of public health measures such as mandatory self-isolation for returned travellers, aimed at preventing onward transmission of newly introduced lineages of SARS-CoV-2.